REFERENCES
- Grinspoon S, Carr A. Cardiovascular risk and body-fat abnormalities in HIV-infected adults. New Engl J Med. 2005;352(1):48–62.
- Butte NF. Carbohydrate and lipid metabolism in pregnancy: normal compared with gestational diabetes mellitus. Am J Clin Nutr. 2000;71(suppl):1256S–1261S.
- Friis-Moller N, Weber R, Reiss P, et al. Cardiovascular dis-ease risk factors in HIV-patients: association with antiretroviral therapy: results from the DAD study. AIDS. 2003;17: 1179–1193.
- Gallant JE, Staszewski S, Pozniak AL, et al. Efficacy and safety of tenofovir DF vs stavudine in combination therapy in antiretroviral-naive patients: a 3-year randomised trial. JAMA. 2004;292:191–201.
- Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treat-ment of High Blood Cholesterol in Adults (Adult Treatment Panel III) Final Report. Circulation. 2002;106: 3143–3421.
- Ridker PM, Rifai N, Cook NR, et al. Non-HDL cholesterol, apolipoproteins A-land B100, standard lipid measures, lipid ratios, and CRP as risk factors for cardiovascular disease in women. JAMA. 2005;294:326–333.
- Hokanson JE, Austin MA. Plasma triglyceride level is a risk factor for cardiovascular disease independent of high-den-sity lipoprotein cholesterol level: a meta-analysis of popula-tion-based prospective studies. J Cardiovasc Risk. 1996; 3(2):213–219.
- Yadav D, Pitchumoni CS. Issues in hyperlipidemic pancre-atitis. J Clin GastroenteroL 2003;36(1):54–62.
- Saadi HF, Kurlander DJ, Erkins JM, Hoogwerf BJ. Severe hypeitriglyceridemia and acute pancreatitis during preg-nancy: treatment with gemfibrozil. Endocrine Pract. 1999;5(1 ):33–36.
- Enquobahrie DA, Williams MA, Qiu C, Luthy DA. Early preg-nancy lipid concentrations and the risk of gestational diabe-tes mellitus. Diabetes Res Clin Pract 2005;70(2):134–142.
- Clausen T, Djurovic S, Heriksen T. Dyslipidemia in early second trimester is mainly a feature of women with early onset pre-eclampsia. BJOG. 2001;108(10):1081–1087.
- Kitajima M, Oka S, Yasuhi I, et al. Maternal serum triglyc-eride at 24-32 weeks' gestation and newborn weight in nondiabetic women with positive diabetic screens. Obstet GynecoL 2001;97:776–780.
- Maternal triglyceride levels and newborn weight in preg-nant women with normal glucose tolerance. Diabetic Med. 2005;22(1):21–25.
- Sarner L, Fakoya A. Acute onset lactic acidosis and pan-creatitis in the third trimester of pregnancy in HIV-1 posi-tive women taking antiretroviral medication. Sex Transm Infect. 2002;78(1):58–59.
- Blanche S, Tardieu M, Rustin P, et al. Persistent mito-chondrial dysfunction and perinatal exposure to antiretroviral nucleoside analogues. Lancet. 1999; 354(9184):1084–1089.
- Public Health Service Task Force recommendations for use of antiretroviral drugs in pregnant HIV-1-infected women for maternal health and interventions to reduce perinatal HIV-1 transmission in the United States. Febru-ary 24, 2005. Available at: http://aidsinfo.nih.gov/guide-lines/perinatal/PER_022405.pdf. Accessed June 3, 2005.
- FDA public health advisory for nevirapine (Viramune). January 19, 2005. Available at: http://www.fda.gov/cder/drug/advisory/nevirapine.htm. Accessed July 10, 2006.